A glp1 receptor agonist diabetes drug ameliorates neurodegeneration in a mouse model of infantile neurometabolic disease

HIGHLIGHTS

• who: L. Poupon-Bejuit from the UCL SchoolUniversity College have published the article: A GLP1 receptor agonist diabetes drug ameliorates neurodegeneration in a mouse model of infantile neurometabolic disease, in the Journal: Scientific Reports Scientific Reports
• what: This investigation demonstrated involvement of the apoptotic mechanism of cell death in the Pla2g6-inad model. The study demonstrates the presence of apoptosis through modulation of BCl-2 family members, which was largely reversed by semaglutide treatment. Preclinical studies using semaglutide for treating different types of neurological diseases such as Parkinson's d ­ isease19,20 and ­stroke10 also . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.